| Impaired action of anxiolytic drugs in mice deficient in cannabinoid CB1 receptors L Urigüen, S Pérez-Rial, C Ledent, T Palomo, J Manzanares Neuropharmacology 46 (7), 966-973, 2004 | 264 | 2004 |
| Immunodensity and mRNA expression of A2A adenosine, D2 dopamine, and CB1 cannabinoid receptors in postmortem frontal cortex of subjects with … L Urigüen, MJ García-Fuster, LF Callado, B Morentin, R La Harpe, ... Psychopharmacology 206, 313-324, 2009 | 137 | 2009 |
| Pretreatment with resveratrol prevents neuronal injury and cognitive deficits induced by perinatal hypoxia-ischemia in rats O Arteaga, M Revuelta, L Urigüen, A Alvarez, H Montalvo, E Hilario PloS one 10 (11), e0142424, 2015 | 102 | 2015 |
| Antinociceptive, behavioural and neuroendocrine effects of CP 55,940 in young rats EM Romero, B Fernández, O Sagredo, N Gomez, L Urigüen, C Guaza, ... Developmental brain research 136 (2), 85-92, 2002 | 94 | 2002 |
| The endocannabinoid system in mental disorders: Evidence from human brain studies I Ibarra-Lecue, F Pilar-Cuéllar, C Muguruza, E Florensa-Zanuy, Á Díaz, ... Biochemical pharmacology 157, 97-107, 2018 | 83 | 2018 |
| Biased agonism of three different cannabinoid receptor agonists in mouse brain cortex R Diez-Alarcia, I Ibarra-Lecue, ÁP Lopez-Cardona, J Meana, ... Frontiers in pharmacology 7, 415, 2016 | 83 | 2016 |
| Chronic cannabis promotes pro-hallucinogenic signaling of 5-HT2A receptors through Akt/mTOR pathway I Ibarra-Lecue, I Mollinedo-Gajate, JJ Meana, LF Callado, R Diez-Alarcia, ... Neuropsychopharmacology 43 (10), 2028-2035, 2018 | 72 | 2018 |
| Neuroprotection by the cannabinoid agonist WIN-55212 in an in vivo newborn rat model of acute severe asphyxia J Martı́nez-Orgado, B Fernández-Frutos, R González, E Romero, ... Molecular brain research 114 (2), 132-139, 2003 | 72 | 2003 |
| Role of endocannabinoid system in mental diseases J Manzanares, L Urigüen, G Rubio, T Palomo Neurotoxicity research 6, 213-224, 2004 | 65 | 2004 |
| Time course of opioid and cannabinoid gene transcription alterations induced by repeated administration with fluoxetine in the rat brain JM Oliva, L Urigüen, S Pérez-Rial, J Manzanares Neuropharmacology 49 (5), 618-626, 2005 | 62 | 2005 |
| Therapeutic targeting of HER2–CB2R heteromers in HER2-positive breast cancer S Blasco-Benito, E Moreno, M Seijo-Vila, I Tundidor, C Andradas, ... Proceedings of the National Academy of Sciences 116 (9), 3863-3872, 2019 | 61 | 2019 |
| Activation of the orphan receptor GPR55 by lysophosphatidylinositol promotes metastasis in triple-negative breast cancer C Andradas, S Blasco-Benito, S Castillo-Lluva, P Dillenburg-Pilla, ... Oncotarget 7 (30), 47565, 2016 | 58 | 2016 |
| Gene expression patterns in brain cortex of three different animal models of depression L Urigüen, D Arteta, R Díez‐Alarcia, M Ferrer‐Alcón, A Diaz, A Pazos, ... Genes, Brain and Behavior 7 (6), 649-658, 2008 | 47 | 2008 |
| Regulation of munc18-1 and syntaxin-1A interactive partners in schizophrenia prefrontal cortex: down-regulation of munc18-1a isoform and 75 kDa SNARE complex after … I Gil-Pisa, E Munarriz-Cuezva, A Ramos-Miguel, L Urigüen, JJ Meana, ... International Journal of Neuropsychopharmacology 15 (5), 573-588, 2012 | 36 | 2012 |
| Behavioral, neurochemical and morphological changes induced by the overexpression of munc18-1a in brain of mice: relevance to schizophrenia L Urigüen, I Gil-Pisa, E Munarriz-Cuezva, E Berrocoso, J Pascau, ... Translational psychiatry 3 (1), e221-e221, 2013 | 34 | 2013 |
| Docosahexaenoic acid reduces cerebral damage and ameliorates long-term cognitive impairments caused by neonatal hypoxia–ischemia in rats O Arteaga, M Revuelta, L Urigüen, L Martínez-Millán, E Hilario, A Álvarez Molecular neurobiology 54, 7137-7155, 2017 | 30 | 2017 |
| Antidepressant-like properties of three new α2-adrenoceptor antagonists C Muguruza, F Rodríguez, I Rozas, JJ Meana, L Urigüen, LF Callado Neuropharmacology 65, 13-19, 2013 | 30 | 2013 |
| Prodynorphin gene deletion increased anxiety-like behaviours, impaired the anxiolytic effect of bromazepam and altered GABAA receptor subunits gene … T Femenía, S Pérez-Rial, L Urigüen, J Manzanares Journal of Psychopharmacology 25 (1), 87-96, 2011 | 27 | 2011 |
| κ‐ and δ‐opioid receptor functional activities are increased in the caudate putamen of cannabinoid CB1 receptor knockout mice L Urigüen, F Berrendero, C Ledent, R Maldonado, J Manzanares European journal of neuroscience 22 (8), 2106-2110, 2005 | 27 | 2005 |
| Effects of 14-methoxymetopon, a potent opioid agonist, on the responses to the tail electric stimulation test and plus-maze activity in male rats: neuroendocrine correlates L Urigüen, B Fernandez, EM Romero, N De Pedro, MJ Delgado, C Guaza, ... Brain research bulletin 57 (5), 661-666, 2002 | 25 | 2002 |
Luis F. CalladoUPV/EHU, CIBERSAM在 ehu.es 的电子邮件经过验证
